AlphaQuest’s Medifast MED Stock Holding History

AlphaQuest’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,068	Closed	-$22.1K	–	1212
2025 Q4	$22.1K	Sell	2,068 -8,045	-80%	-$96.3K	﹤0.01%	2086
2025 Q3	$138K	Buy	10,113 +10,058	+18,287%	+$140K	0.01%	1583
2025 Q2	$773	Sell	55 -180	-77%	-$2.37K	﹤0.01%	1935
2025 Q1	$3.17K	Buy	+235	New	+$3.53K	﹤0.01%	1885
2024 Q4	–	Sell	-501	Closed	-$9.59K	–	1903
2024 Q3	$9.59K	Buy	+501	New	+$9.65K	﹤0.01%	1551
2024 Q2	–	Sell	-1	Closed	-$38	–	1766
2024 Q1	$38	Buy	+1	New	+$48	﹤0.01%	1614

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AlphaQuest's MED Position: Q1 2026 in Review

AlphaQuest sold out of Medifast (MED) in Q1 2026, closing a stake of 2,068 shares — an estimated $22.1K sold.

AlphaQuest first reported a position in MED in Q1 2024 and held it in 6 quarters. The position peaked at $138K in Q3 2025. 112 funds tracked by Wall St. Rank hold MED as of Q1 2026.

AlphaQuest reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 2,068 Medifast shares in Q1 2026, an estimated $22.1K.
AlphaQuest first reported a position in Medifast in Q1 2024 and held it in 6 quarters.
AlphaQuest's Medifast position peaked at $138K in Q3 2025.
112 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.